Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1993 Sep;37(9):2007–2008. doi: 10.1128/aac.37.9.2007

Ofloxacin susceptibilities of 5,667 Neisseria gonorrhoeae strains isolated in Hong Kong.

K M Kam 1, K K Lo 1, C F Lai 1, Y S Lee 1, C B Chan 1
PMCID: PMC188111  PMID: 8239622

Abstract

Of 5,667 strains of Neisseria gonorrhoeae isolated from the Government Social Hygiene (sexually transmitted disease) Clinics in Hong Kong from 1990 to 1992, there was a trend toward an increase in the percentage of strains resistant in vitro to 0.01 and 0.1 microgram of ofloxacin per ml, with 54.3 and 5.5% resistant strains, respectively, in January 1990, rising to 95.3 and 41.5%, respectively, in December 1992. The percentage of strains for which the MIC is > 1 microgram/ml remains stable, and no clinical failure has yet been seen. This trend of decreasing susceptibility warrants close monitoring when ofloxacin is used as first-line treatment for gonorrhea.

Full text

PDF
2007

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Batteiger B. E., Jones R. B., White A. Efficacy and safety of ofloxacin in the treatment of nongonococcal sexually transmitted disease. Am J Med. 1989 Dec 29;87(6C):75S–77S. [PubMed] [Google Scholar]
  2. Black J. R., Long J. M., Zwickl B. E., Ray B. S., Verdon M. S., Wetherby S., Hook E. W., 3rd, Handsfield H. H. Multicenter randomized study of single-dose ofloxacin versus amoxicillin-probenecid for treatment of uncomplicated gonococcal infection. Antimicrob Agents Chemother. 1989 Feb;33(2):167–170. doi: 10.1128/aac.33.2.167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Boslego J. W., Hicks C. B., Greenup R., Thomas R. J., Wiener H. A., Ciak J., Tramont E. C. A prospective randomized trial of ofloxacin vs. doxycycline in the treatment of uncomplicated male urethritis. Sex Transm Dis. 1988 Oct-Dec;15(4):186–191. doi: 10.1097/00007435-198810000-00002. [DOI] [PubMed] [Google Scholar]
  4. Chandeying V., Sutthijumroon S., Tungphaisal S. Evaluation of ofloxacin in the treatment of mucopurulent cervicitis: response of chlamydia-positive and chlamydia-negative forms. J Med Assoc Thai. 1989 Jun;72(6):331–337. [PubMed] [Google Scholar]
  5. Clendennen T. E., 3rd, Hames C. S., Kees E. S., Price F. C., Rueppel W. J., Andrada A. B., Espinosa G. E., Kabrerra G., Wignall F. S. In vitro antibiotic susceptibilities of Neisseria gonorrhoeae isolates in the Philippines. Antimicrob Agents Chemother. 1992 Feb;36(2):277–282. doi: 10.1128/aac.36.2.277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Clendennen T. E., Echeverria P., Saengeur S., Kees E. S., Boslego J. W., Wignall F. S. Antibiotic susceptibility survey of Neisseria gonorrhoeae in Thailand. Antimicrob Agents Chemother. 1992 Aug;36(8):1682–1687. doi: 10.1128/aac.36.8.1682. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Covino J. M., Cummings M., Smith B., Benes S., Draft K., McCormack W. M. Comparison of ofloxacin and ceftriaxone in the treatment of uncomplicated gonorrhea caused by penicillinase-producing and non-penicillinase-producing strains. Antimicrob Agents Chemother. 1990 Jan;34(1):148–149. doi: 10.1128/aac.34.1.148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Faro S., Martens M. G., Maccato M., Hammill H. A., Roberts S., Riddle G. Effectiveness of ofloxacin in the treatment of Chlamydia trachomatis and Neisseria gonorrhoeae cervical infection. Am J Obstet Gynecol. 1991 May;164(5 Pt 2):1380–1383. doi: 10.1016/0002-9378(91)91476-d. [DOI] [PubMed] [Google Scholar]
  9. Gransden W. R., Warren C., Phillips I. 4-Quinolone-resistant Neisseria gonorrhoeae in the United Kingdom. J Med Microbiol. 1991 Jan;34(1):23–27. doi: 10.1099/00222615-34-1-23. [DOI] [PubMed] [Google Scholar]
  10. Ibsen H. H., Møller B. R., Halkier-Sørensen L., From E. Treatment of nongonococcal urethritis: comparison of ofloxacin and erythromycin. Sex Transm Dis. 1989 Jan-Mar;16(1):32–35. doi: 10.1097/00007435-198901000-00007. [DOI] [PubMed] [Google Scholar]
  11. Kam K. M., Lai C. F., Egglestone S., Chan C. B. Patterns of antibiotic susceptibility of gonococci isolated in Hong Kong, 1987-1990. Sex Transm Dis. 1992 Sep-Oct;19(5):284–287. doi: 10.1097/00007435-199209000-00008. [DOI] [PubMed] [Google Scholar]
  12. Kawamura N., Nakajima N., Hoshino H., Tanaka M., Koinuma A. Effect of ofloxacin in the treatment of genitourinary tract infection with Ureaplasma urealyticum. Hinyokika Kiyo. 1989 Dec;35(12):2149–2153. [PubMed] [Google Scholar]
  13. Kumamoto Y., Sakai S., Hirose T., Tsunekawa T., Machida T., Kiyota H., Okazaki T., Kishi H., Higashihara E., Aso Y. [Efficacy of ofloxacin in sexually transmitted male urethritis and cervicitis]. Jpn J Antibiot. 1988 Oct;41(10):1445–1479. [PubMed] [Google Scholar]
  14. Sanders C. C. Review of preclinical studies with ofloxacin. Clin Infect Dis. 1992 Feb;14(2):526–538. doi: 10.1093/clinids/14.2.526. [DOI] [PubMed] [Google Scholar]
  15. Sanders W. E., Jr Oral ofloxacin: a critical review of the new drug application. Clin Infect Dis. 1992 Feb;14(2):539–554. doi: 10.1093/clinids/14.2.539. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES